FGC
VIVO

Financial Gravity Companies’s Meridian Bioscience Inc VIVO Stock Holding History

Financial Gravity Companies’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		$40K Buy
+2,528
New +$43.1K 0.04% 396
2018
Q1 		$3K Buy
213
+154
+261% +$2.28K ﹤0.01% 900
2017
Q4 		$1K Buy
+59
New +$864 ﹤0.01% 1265

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Financial Gravity Companies's VIVO Position: Q4 2018 in Review

Financial Gravity Companies opened a new position in Meridian Bioscience Inc (VIVO) in Q4 2018: 2,528 shares worth $40K. The stake represents 0.04% of the portfolio and ranks #396 among its holdings. This is a return to the name: Financial Gravity Companies previously reported a position in VIVO as recently as Q1 2018.

Financial Gravity Companies first reported a position in VIVO in Q4 2017 and has held it in 3 quarters since. 191 funds tracked by Wall St. Rank hold VIVO as of Q4 2018.

  • Financial Gravity Companies held 2,528 shares of Meridian Bioscience Inc worth $40K as of Q4 2018.
  • Meridian Bioscience Inc was a new Financial Gravity Companies position in Q4 2018.
  • Meridian Bioscience Inc made up 0.04% of Financial Gravity Companies's portfolio in Q4 2018, its #396 holding.
  • Financial Gravity Companies first reported a position in Meridian Bioscience Inc in Q4 2017 and has held it in 3 quarters since.
  • 191 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q4 2018.

Based on Financial Gravity Companies's 13F filing for Q4 2018, filed 4 Feb 2019.